1 / 1
Ritlecitinib(Litfulo)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Pfizer Inc.
Formulation:
CAPSULE
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Litfulo(Ritlecitinib) Instructions:Uses,Dosage, Side Effects
Ritlecitinib was developed by Pfizer, an American pharmaceutical company. It was approved for marketing by the U.S. FDA on June 23, 2023. In China, ritlecitinib was approved for marketing on October 18, 2023.
Ritlecitinib has not been explicitly included in China's National Medical Insurance Catalog. Patients may need to purchase the drug at their own expense or alleviate the financial burden through other medical insurance plans, drug subsidy programs, or preferential programs offered by pharmaceutical companies.
